These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 75861

  • 1. A new passive anterior rhinometric method for clinical study of nasal decongestant.
    Cho YW.
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):63-7. PubMed ID: 75861
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Variability in nasal resistance measurements.
    Cole P, Fastag O, Forsyth R.
    J Otolaryngol; 1980 Aug; 9(4):309-15. PubMed ID: 6158578
    [Abstract] [Full Text] [Related]

  • 6. Objective assessment of nasal airway in children: an evaluation of decongestant therapy.
    Mascia AV.
    Ann Allergy; 1968 Sep; 26(9):470-5. PubMed ID: 4176197
    [No Abstract] [Full Text] [Related]

  • 7. Nasal decongestant activity of pseudoephedrine.
    Roth RP, Cantekin EI, Bluestone CD, Welch RM, Cho YW.
    Ann Otol Rhinol Laryngol; 1977 Sep; 86(2 pt. 1):235-42. PubMed ID: 322570
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Rhinomanometry. III. Procedures and criteria for distinction between skeletal stenosis and mucosal swelling.
    Broms P.
    Acta Otolaryngol; 1982 Sep; 94(3-4):361-70. PubMed ID: 6183919
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The determination of the optimal oral dose of pseudoephedrine for nasal decongestion using nasal histamine challenge and anterior rhinometry [proceedings].
    Bagg LR, Empey DW, Hughes DT, John GC, Letley E, Young GA.
    Br J Clin Pharmacol; 1979 Apr; 7(4):426P. PubMed ID: 87212
    [No Abstract] [Full Text] [Related]

  • 12. [The effect of nasal dilators and local decongestants on the nasal airway].
    Akçam T, Karakoç O, Karahatay S, Yetişer S.
    Kulak Burun Bogaz Ihtis Derg; 2005 Apr; 15(5-6):97-102. PubMed ID: 16444089
    [Abstract] [Full Text] [Related]

  • 13. Nasal airflow asymmetry and the effects of a topical nasal decongestant.
    Williams RG, Eccles R.
    Rhinology; 1992 Dec; 30(4):277-82. PubMed ID: 1281924
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Decongestant activity of a new formulation of xylometazoline nasal spray: a double-blind, randomized versus placebo and reference drugs controlled, dose-effect study.
    Castellano F, Mautone G.
    Drugs Exp Clin Res; 2002 Dec; 28(1):27-35. PubMed ID: 12073765
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of topical tuaminoheptane combined with N-acetyl-cysteine in reducing nasal resistance. A double-blind rhinomanometric study versus xylometazoline and placebo.
    Cogo A, Chieffo A, Farinatti M, Ciaccia A.
    Arzneimittelforschung; 1996 Apr; 46(4):385-8. PubMed ID: 8740084
    [Abstract] [Full Text] [Related]

  • 19. The effect of rapid maxillary expansion on nasal airway resistance.
    White BC, Woodside DG, Cole P.
    J Otolaryngol; 1989 Jun; 18(4):137-43. PubMed ID: 2472491
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.